Konstantin Chegaev

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Drug Delivery Drug Delivery professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

The intention of this Special Issue is to focus on new achievements in the design, preparation, and in vitro and in vivo biological evaluation of bioactive molecules that can result in the development of natural or artificial potent compounds looking for promising pharmaceuticals and agrochemicals [...]

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Collaborators (11)

Chiara Riganti

tenured assistant professor

University of Turin

ITALY

View details

Marco Vincenti

Professore Ordinario - Full Professor

Università degli Studi di Torino

ITALY

View details

Cristina Parisi

Assistant Professor

University of Catania

ITALY

View details

Dr. Federica Sodano

Assistant Professor

University of Naples Federico II

ITALY

View details

Maria Grazia RIMOLI

associate professor

University of Naples Federico II

ITALY

View details

Magdalena Kostrzewa

University of Bologna

ITALY

View details

francesca spyrakis

Associate Professor

University of Turin

ITALY

View details

Massimo Bertinaria

University of Turin

ITALY

View details

Loretta Lazzarato

Professore associato

Università degli Studi di Torino

ITALY

View details

Federica Blua

University of Turin

ITALY

View details

Marina Gallarate

University of Turin

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Konstantin Chegaev

Research Interests

Explore related searches

Contact this professor

Articles (11)

Synthesis of Arginase Inhibitors: An Overview

A new biocompatible butyric acid-releasing glucosamine derivative for transdermal delivery

Special Issue “Development and Synthesis of Biologically Active Compounds”

Development of targeted lipid nanoparticles for the combined therapy of triple negative breast cancer: Can curcumin and 6-aminoflavone promote doxorubicin in vitro efficacy?

Opportunities and Challenges of Arginase Inhibitors in Cancer: A Medicinal Chemistry Perspective

Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells

Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage

Multitarget Antioxidant NO-Donor Organic Nitrates: A Novel Approach to Overcome Nitrates Tolerance, an Ex Vivo Study

<i>N</i>-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation

Naked and Decorated Nanoparticles Containing H<sub>2</sub>S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells

NO release regulated by doxorubicin as the green light-harvesting antenna

Collaborators (11)

Chiara Riganti

Marco Vincenti

Cristina Parisi

Dr. Federica Sodano

Maria Grazia RIMOLI

Magdalena Kostrzewa

francesca spyrakis

Massimo Bertinaria

Loretta Lazzarato

Federica Blua

Marina Gallarate

Make your next move.